Serveur d'exploration sur la Covid et les espaces publics

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.

Identifieur interne : 000100 ( Main/Exploration ); précédent : 000099; suivant : 000101

Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.

Auteurs : Leigh Turner [États-Unis]

Source :

RBID : pubmed:32464095

Descripteurs français

English descriptors

Abstract

In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.

DOI: 10.1016/j.stem.2020.05.003
PubMed: 32464095
PubMed Central: PMC7203029


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.</title>
<author>
<name sortKey="Turner, Leigh" sort="Turner, Leigh" uniqKey="Turner L" first="Leigh" last="Turner">Leigh Turner</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455</wicri:regionArea>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32464095</idno>
<idno type="pmid">32464095</idno>
<idno type="doi">10.1016/j.stem.2020.05.003</idno>
<idno type="pmc">PMC7203029</idno>
<idno type="wicri:Area/Main/Corpus">000207</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000207</idno>
<idno type="wicri:Area/Main/Curation">000207</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000207</idno>
<idno type="wicri:Area/Main/Exploration">000207</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.</title>
<author>
<name sortKey="Turner, Leigh" sort="Turner, Leigh" uniqKey="Turner L" first="Leigh" last="Turner">Leigh Turner</name>
<affiliation wicri:level="2">
<nlm:affiliation>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455</wicri:regionArea>
<placeName>
<region type="state">Minnesota</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cell stem cell</title>
<idno type="eISSN">1875-9777</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Commerce (MeSH)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (psychology)</term>
<term>Coronavirus Infections (therapy)</term>
<term>Fear (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Marketing (MeSH)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Pneumonia, Viral (psychology)</term>
<term>Pneumonia, Viral (therapy)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Stem Cell Transplantation (economics)</term>
<term>Stem Cell Transplantation (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Betacoronavirus (MeSH)</term>
<term>Commerce (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Infections à coronavirus (psychologie)</term>
<term>Infections à coronavirus (thérapie)</term>
<term>Marketing (MeSH)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Peur (MeSH)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Pneumopathie virale (psychologie)</term>
<term>Pneumopathie virale (thérapie)</term>
<term>Transplantation de cellules souches (méthodes)</term>
<term>Transplantation de cellules souches (économie)</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en">
<term>Stem Cell Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Stem Cell Transplantation</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Transplantation de cellules souches</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr">
<term>Transplantation de cellules souches</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Betacoronavirus</term>
<term>COVID-19</term>
<term>Commerce</term>
<term>Fear</term>
<term>Humans</term>
<term>Marketing</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Commerce</term>
<term>Humains</term>
<term>Marketing</term>
<term>Peur</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32464095</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>06</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1875-9777</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>26</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2020</Year>
<Month>06</Month>
<Day>04</Day>
</PubDate>
</JournalIssue>
<Title>Cell stem cell</Title>
<ISOAbbreviation>Cell Stem Cell</ISOAbbreviation>
</Journal>
<ArticleTitle>Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.</ArticleTitle>
<Pagination>
<MedlinePgn>806-810</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1934-5909(20)30201-0</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stem.2020.05.003</ELocationID>
<Abstract>
<AbstractText>In the midst of a global public health emergency, some businesses are taking advantage of widespread fears by marketing purported stem cell treatments for COVID-19. Such businesses target prospective clients with misleading claims, expose patients to potentially risky stem cell-based products, and undermine efforts to develop evidence-based treatments for COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Turner</LastName>
<ForeName>Leigh</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Center for Bioethics, School of Public Health, and College of Pharmacy, University of Minnesota, 410 Church Street SE, N520, Minneapolis, MN 55455, USA. Electronic address: turne462@umn.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>05</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cell Stem Cell</MedlineTA>
<NlmUniqueID>101311472</NlmUniqueID>
<ISSNLinking>1875-9777</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005239" MajorTopicYN="N">Fear</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D040541" MajorTopicYN="Y">Marketing</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D033581" MajorTopicYN="N">Stem Cell Transplantation</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>Declaration of Interests L.T. has reported to the FDA numerous businesses selling unlicensed and unproven stem cell interventions. On a pro bono basis, L.T. filed an expert opinion report and rebuttal report supporting plaintiffs in a lawsuit filed against a business marketing purported stem cell interventions. L.T. was also deposed in this case and was examined and cross-examined in a court hearing. This work was also conducted on a pro bono basis. L.T. is a member of the International Society for Cell and Gene Therapy and a member of the International Society for Stem Cell Research.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>6</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>5</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32464095</ArticleId>
<ArticleId IdType="pii">S1934-5909(20)30201-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.stem.2020.05.003</ArticleId>
<ArticleId IdType="pmc">PMC7203029</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2020 Mar 24;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32208486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2017 Jul 5;9(397):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28679655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Medicine (Baltimore). 2020 Jul 31;99(31):e21429</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32756149</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2016 May 13;352(6287):776-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27174977</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Stem Cell. 2016 Aug 4;19(2):154-157</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27374789</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2020 Jun 4;55(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32265310</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pain Physician. 2020 Mar;23(2):E71-E83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32214286</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>NPJ Regen Med. 2018 Feb 19;3:5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29479481</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aging Dis. 2020 Mar 9;11(2):216-228</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32257537</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Minnesota</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Minnesota">
<name sortKey="Turner, Leigh" sort="Turner, Leigh" uniqKey="Turner L" first="Leigh" last="Turner">Leigh Turner</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Wicri/explor/CovidPublicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000100 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000100 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Wicri
   |area=    CovidPublicV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32464095
   |texte=   Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32464095" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidPublicV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Tue Dec 15 17:23:28 2020. Site generation: Wed Jan 27 15:07:40 2021